2019
DOI: 10.1111/1754-9485.12850
|View full text |Cite
|
Sign up to set email alerts
|

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management

Abstract: Introduction: Assess survival of patients with anaplastic glioma (AG) and the relationship to molecular subtype. Methods: Patients with AG managed with IMRT between 2008 and 2014 were entered into a prospective database assessing relapse-free survival (RFS) and overall survival (OS). Isocitrate dehydrogenase (IDH) mutations were assessed prospectively from 2011, and subsequent testing of historical patients allowing categorisation under WHO 2016 classification as anaplastic astrocytoma IDH wild type (AAwt), an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…There is a big survival difference between IDH1-mutated vs. wild-type gliomas. Although IDH1 mutant glioblastoma has still significantly worse outcomes than grade II and III gliomas, there are no differences in survival between IDH mutant grades II and III [40]. For this reason, Shirahata et al proposed a novel, improved grading system for IDH-mutant astrocytic gliomas [41].…”
Section: Radiomic Data For the Genetic And Molecular Features Of Lggsmentioning
confidence: 99%
“…There is a big survival difference between IDH1-mutated vs. wild-type gliomas. Although IDH1 mutant glioblastoma has still significantly worse outcomes than grade II and III gliomas, there are no differences in survival between IDH mutant grades II and III [40]. For this reason, Shirahata et al proposed a novel, improved grading system for IDH-mutant astrocytic gliomas [41].…”
Section: Radiomic Data For the Genetic And Molecular Features Of Lggsmentioning
confidence: 99%
“…Whilst this study is limited in description of late effects of IMRT, the functional endpoints of excellent performance status and sustained employment suggest that in the median follow-up period of survivors the impact of IMRT is acceptable. This has also been demonstrated in a larger cohort from multiple brain regional sites where functional status in the years post IMRT is high, and most latent impact arises from the immediate postoperative morbidity [13,[30][31][32].…”
Section: Discussionmentioning
confidence: 67%
“…As knowledge of IDH mutated glioma expands then the potential to predict more adverse tumour subsites may infer a need for a more aggressive initial approach aimed at near-total resection. An expanding knowledge of molecular features, such as CDKN2A heterogenous deletion [ 35 , 36 ], may then become factors that influence the utilisation of a more aggressive approach with repeat craniotomy seeking maximal tumour reduction prior to delivery of IMRT.…”
Section: Discussionmentioning
confidence: 99%